Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-062086
Filing Date
2018-12-11
Accepted
2018-12-11 19:13:38
Documents
2
Period of Report
2018-12-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1613
2 POA DOCUMENT poa.txt EX-24.3_820655 3622
  Complete submission text file 0001209191-18-062086.txt   6698
Mailing Address C/O TESARO, INC. 1000 WINTER ST., STE 3300 WALTHAM MA 02451
Business Address
Hedley Mary Lynne (Reporting) CIK: 0001340823 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35890 | Film No.: 181229784

Mailing Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104
Business Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations